Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/TG Therapeutics, Inc./ 10-K

Annual Report · 10-K

TG Therapeutics, Inc.

TGTXNASDAQEQUITYCurrent

Annual Report

Filed Feb 27, 2026Accepted Feb 27, 2026, 12:05 PM ESTCIK 1001316Accession 0001437749-26-006133
View company →Permanent SEC source ↗
Share

Company context

Current securities

TGTXNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingSep 10, 2026
  2. 10-Q filingAug 5, 2026
  3. Results of Operations and Financial ConditionAug 3, 2026
  4. 4 filingJun 15, 2026
  5. 4 filingJun 15, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗